“$1 billion in annual revenue is easily achievable.”“$1 billion in annual revenue is easily achievable.”

The True Value of Data Availability: Celestia’s Revenue Potential

2025/03/11 12:50
5 min read

Author: DE Analytics

Compiled by: Felix, PANews

This article aims to explore Celestia's revenue potential, point out common misconceptions and narratives that are currently flawed or at least lack substance, and finally propose hypotheses to illustrate Celestia's true revenue potential.

“DA is a commodity”?

A common criticism I see about Celestia’s revenue model is that in the long run, DA (data availability) should be considered a commodity, meaning that fees will inevitably trend towards the bottom.

For this to be true, DA as a resource must be the same across all services. This is not the case for the following reasons:

Celestia DA ≠ any other DA

An important thing to note here is that Celestia not only provides DA, it also provides consensus for rollups. Obviously, some DA providers offer stronger security guarantees than others. Additionally, some providers will have stronger network effects. This alone differentiates the DA service, which means it is not a commodity by definition.

Let’s look at it from the perspective of rollup.

Rollup POV

Rollups are consumers of DA and consensus. They don’t just choose who is the cheapest, they also have to consider security. In addition, they want to use what everyone else is using so they know they won’t get scammed because it’s battle-tested.

Additionally, seeing other protocols switch can instill confidence, further differentiating DA providers from one another. This is a network effect in itself — one that cannot be forked and is difficult to replicate.

So DA is not a pure commodity – but how should it be valued?

Given that DA is not a commodity, it is reasonable for the transaction price to have a certain premium relative to its cost, but it should not be so high that Rollups are prevented from choosing it. After all, it should provide positive results for these rollups. Currently, this positive factor is a significant reduction in fees. Let’s take a look at these data:

Fees are intentionally low

You may have seen people complaining on Twitter that Celestia's current revenue is too low and its valuation is too high, even after a huge drop from its ATH. But they completely ignore that the current revenue is deliberately low. Here's why:

Gaining market share

Low fees are a strategic choice for Celestia to gain market share and beat competitors. The goal is to attract users with free DA, let them try the product, and then become dependent. Once you have a large number of users (rollup), monetization is not a problem. However, gaining users and beating competitors is difficult, which is why you can't set high fees at the beginning and expect a large influx of users.

Celestia co-founder Mustafa Al-Bassam once discussed this point.

Celestia's estimated annual income

Recently, Mustafa Al-Bassam started a discussion on the Celestia forum about whether to gradually increase the current fees. The first proposed increase was 4 times (possibly more), and the table shows fee increases ranging from 2 times to 128 times.

The True Value of Data Availability: Celestia’s Revenue Potential

There is also discussion about anchoring fees to USD and protecting them from TIA volatility. It is worth noting that this is just the beginning and there is still much discussion to be had.

Now that we have some figures available, we can try to assess DA fee income. This is a very difficult exercise, so some assumptions must be made.

Assumptions

As more modular projects enter mainnet, the total data released by Celestia will increase significantly (currently 1.5TB). So far, we have only seen Eclipse stress-test its chain, and more are expected in the future.

To provide some context, Initia, Movement, and Abstract are just some of the many projects laying the foundation for building killer apps. But what do all of these apps have in common? They will completely rely on having secure, fast, and cheap DA.

With this in mind, let's assume that Celestia will eventually publish 50TB of data per year and continue to grow.

TIA Revenue Estimates

The total amount of fees paid by TIA so far is 313,000. At TIA $3.2, that’s about $1 million. But again, these fees are intentionally set low.

If you raise the fee by 15x, it’s still much cheaper than ETH DA. Still a great choice for rollups without adding too much cost: ~66x cheaper than EIP-4844. While you can adjust it higher or lower, 15x is used as a baseline here.

Revenues are now $15 million.

Next, substitute the DA requirement into the formula:

$15 million x 50 TB = $750 million in annual revenue.

If the total figures released increase year-over-year, annual revenues could easily exceed $1 billion.

Final Thoughts

There are actually many variables that affect this calculation, and it's obviously not that simple. Increase or decrease certain variables, and the income will adjust accordingly. But since people like exact numbers, here's an exact number that most people can agree on.

Of course you can continue to tweak the numbers and come up with different revenues, but my personal view is that $1 billion in annual revenue is easily achievable.

The above is just my personal opinion, DYOR.

Related reading: Celestia is suspected of "pumping up shipments": selling coins is packaged as financing before large-scale unlocking

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.
Tags:

You May Also Like

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

The surge follows a difficult August, when investors pulled out more than $750 million while rotating capital into Ethereum-focused funds. […] The post Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge appeared first on Coindoo.
Share
Coindoo2025/09/18 01:15
CME Group to launch options on XRP and SOL futures

CME Group to launch options on XRP and SOL futures

The post CME Group to launch options on XRP and SOL futures appeared on BitcoinEthereumNews.com. CME Group will offer options based on the derivative markets on Solana (SOL) and XRP. The new markets will open on October 13, after regulatory approval.  CME Group will expand its crypto products with options on the futures markets of Solana (SOL) and XRP. The futures market will start on October 13, after regulatory review and approval.  The options will allow the trading of MicroSol, XRP, and MicroXRP futures, with expiry dates available every business day, monthly, and quarterly. The new products will be added to the existing BTC and ETH options markets. ‘The launch of these options contracts builds on the significant growth and increasing liquidity we have seen across our suite of Solana and XRP futures,’ said Giovanni Vicioso, CME Group Global Head of Cryptocurrency Products. The options contracts will have two main sizes, tracking the futures contracts. The new market will be suitable for sophisticated institutional traders, as well as active individual traders. The addition of options markets singles out XRP and SOL as liquid enough to offer the potential to bet on a market direction.  The options on futures arrive a few months after the launch of SOL futures. Both SOL and XRP had peak volumes in August, though XRP activity has slowed down in September. XRP and SOL options to tap both institutions and active traders Crypto options are one of the indicators of market attitudes, with XRP and SOL receiving a new way to gauge sentiment. The contracts will be supported by the Cumberland team.  ‘As one of the biggest liquidity providers in the ecosystem, the Cumberland team is excited to support CME Group’s continued expansion of crypto offerings,’ said Roman Makarov, Head of Cumberland Options Trading at DRW. ‘The launch of options on Solana and XRP futures is the latest example of the…
Share
BitcoinEthereumNews2025/09/18 00:56
The FDA Is Trying To Make Corporate Free Speech Situational

The FDA Is Trying To Make Corporate Free Speech Situational

The post The FDA Is Trying To Make Corporate Free Speech Situational appeared on BitcoinEthereumNews.com. BENSENVILLE, ILLINOIS – SEPTEMBER 10: Flanked by U.S. Attorney General Pam Bondi (rear), and FDA Commissioner Marty Makary (R), Secretary of Health and Human Services Robert F. Kennedy Jr. speaks to the press outside Midwest Distribution after it was raided by federal agents on September 10, 2025 in Bensenville, Illinois. According to the company, various e-liquids were seized in the raid. (Photo by Scott Olson/Getty Images) Getty Images While running for President in 2008, Barack Obama famously chanted “Yes we can.” Love or hate his political views, Obama’s politics were quite effective. He was asking voters to think big, to envision a much better future. Advertisers no doubt approved. That’s because ads routinely evoke things not as they are, but as they could be. Gyms and exercise equipment companies don’t promote their locations and equipment with flabby, lumbering people, rather their ads show fit, upright, energetic individuals. A look ahead. Restaurants do the same with ads showing happy people enjoying impressively put together plates of food. Conversely, ads meant to convince smokers to quit have not infrequently shown the worst of the worst future downsides of the habit. The nature of advertising comes to mind as FDA commissioner Marty Makary puzzlingly brags that “The Trump Administration Is Taking On Big Pharma” in the New York Times. Makary laments pharmaceutical ads that “are filled with dancing patients, glowing smiles and catch jingles that drown out the fine print.” Not explained is whether Makary would be happier if drug companies placed ads with immobile patients, frowns, and funereal music. Seriously, what does he expect? Does he want drug companies to commit billions to drug development to accompany their achievements with imagery defined by misery? Has Makary stopped to contemplate the myriad shareholders lawsuits drugmakers would face if, upon risking staggering sums meant…
Share
BitcoinEthereumNews2025/09/18 06:29